

AIM WINNERS & LOSERS: Mercantile Ports jumps on pact; Avacta recovers


IN BRIEF: Avacta signs distribution deal for its Covid test


UK shareholder meetings calendar - next 7 days


(Sharecast News) - Diagnostics and cancer therapies developer Avacta Group has entered into a non-exclusive distribution agreement with life science p...


(Sharecast News) - Diagnostics and cancer therapies developer Avacta Group has received notice of registration of its 'AffiDX' SARS-CoV-2 antigen late...


Avacta Covid lateral flow test gets regulatory green light in EU


IN BRIEF: Avacta Covid lateral flow test gets regulatory green light


(Sharecast News) - Diagnostics and cancer therapy developer Avacta Group announced on Monday that the Medicines and Healthcare products Regulatory Age...